BIT
NKTR icon

BlackRock Institutional Trust’s Nektar Therapeutics NKTR Stock Holding History

BlackRock Institutional Trust’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$46.1M Buy
250,346
+26,771
+12% +$5.44M 0.01% 1402
2016
Q3 		$57.6M Buy
223,575
+4,128
+2% +$1.06M 0.01% 1198
2016
Q2 		$46.8M Buy
219,447
+1,383
+0.6% +$309K 0.01% 1270
2016
Q1 		$45M Sell
218,064
-1,609
-0.7% -$309K 0.01% 1295
2015
Q4 		$55.5M Buy
219,673
+8,117
+4% +$1.67M 0.01% 1175
2015
Q3 		$34.8M Sell
211,556
-2,778
-1% -$491K 0.01% 1460
2015
Q2 		$40.2M Sell
214,334
-76,711
-26% -$13.2M 0.01% 1428
2015
Q1 		$48M Buy
291,045
+64,058
+28% +$13.2M 0.01% 1349
2014
Q4 		$52.8M Sell
226,987
-3,227
-1% -$690K 0.01% 1267
2014
Q3 		$41.7M Sell
230,214
-5,090
-2% -$974K 0.01% 1374
2014
Q2 		$45.2M Sell
235,304
-2,226
-0.9% -$394K 0.01% 1384
2014
Q1 		$43.2M Buy
237,530
+25,025
+12% +$4.95M 0.01% 1392
2013
Q4 		$36.2M Sell
212,505
-5,409
-2% -$872K 0.01% 1500
2013
Q3 		$34.1M Sell
217,914
-1,182
-0.5% -$219K 0.01% 1462
2013
Q2 		$38M Buy
+219,096
New +$33.6M 0.01% 1329

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

BlackRock Institutional Trust's NKTR Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Nektar Therapeutics (NKTR) stake by 12% in Q4 2016, buying an estimated $5.44M and bringing the position to 250,346 shares worth $46.1M. The position accounts for 0.01% of the portfolio, ranked #1402.

BlackRock Institutional Trust first reported a position in NKTR in Q2 2013 and has held it in 15 quarters since. The position peaked at $57.6M in Q3 2016. 199 funds tracked by Wall St. Rank hold NKTR as of Q4 2016.

  • BlackRock Institutional Trust held 250,346 shares of Nektar Therapeutics worth $46.1M as of Q4 2016.
  • BlackRock Institutional Trust bought 26,771 Nektar Therapeutics shares in Q4 2016, an estimated $5.44M.
  • Nektar Therapeutics made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1402 holding.
  • BlackRock Institutional Trust first reported a position in Nektar Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Nektar Therapeutics position peaked at $57.6M in Q3 2016.
  • 199 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.